Investigating the potential of Oxymatrine as a psoriasis therapy.
Sign Up to like & getrecommendations! Published in 2017 at "Chemico-biological interactions"
DOI: 10.1016/j.cbi.2017.04.020
Abstract: Psoriasis vulgaris is a chronic inflammatory skin disease, stubbornly intractable, with substantial consequences for patient physical and mental welfare. Approaches currently available to treat psoriasis are not satisfactory due to undesirable side-effects or expense. Psoriasis… read more here.
Keywords: oxymatrine psoriasis; psoriasis therapy; skin; potential oxymatrine ... See more keywords
Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.06.057
Abstract: Psoriasis is a systemic inflammatory disease associated with increased risk of comorbidities, such as psoriatic arthritis, Crohn's disease, malignancy, obesity, and cardiovascular diseases. These factors have a significant impact on the decision to use one… read more here.
Keywords: therapy; psoriasis comorbidities; therapy patient; psoriasis therapy ... See more keywords
Are new variants of psoriasis therapy (IL‐17 inhibitors) safe?
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14509
Abstract: Psoriasis is a chronic, recurrent, inflammatory, and proliferative skin disease. Its etiology has not yet been fully assessed, but undoubtedly it is a multifaceted disease. The key role in its pathomechanism is played by genetic,… read more here.
Keywords: therapy; variants psoriasis; new variants; psoriasis therapy ... See more keywords
Real‐world experience versus clinical trials: pros and cons in psoriasis therapy evaluation
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Dermatology"
DOI: 10.1111/ijd.15644
Abstract: cons in psoriasis therapy evaluation Dear Editor, Safety and efficacy data rely on two ancillary sources, namely clinical trials and real-world experience. The two sources differ and complement one another in many aspects: for example,… read more here.
Keywords: safety; rwe; clinical trials; efficacy ... See more keywords